VYGR - Voyager Therapeutics Inc
Voyager Therapeutics Inc Logo

VYGR - Voyager Therapeutics Inc

https://www.voyagertherapeutics.com
Hold Momentum: Bearish
Recent News
Powered by Alpha Vantage
AI Tools
Key Metrics
Trend: Range-Bound
As of 2025-09-10 (Snapshot)

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, is focused on developing treatments for patients with severe neurological diseases. The company is headquartered in Cambridge, Massachusetts.

52W High
$8.28
52W Low
$2.65
MA Status:
50D: Above 200D: Above
Beta (~1 neutral, <0.9 lower risk)
0.90
Valuation
As of 2025-06-30 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
2.59
EV/Revenue (<3 favorable)
5.26
P/S (TTM) (<3 favorable)
5.52
P/B (<3 favorable)
0.96
Ownership
Balanced
Source: Overview
Insiders (1–5% typical)
16.52%
Institutions (25–75% balanced)
60.09%
Shares Outstanding
55,469,000
Float
45,839,400
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-06-30 (Overview)
Revenue (TTM)
42,580,000
Gross Profit (TTM)
-85,824,000
EPS (TTM)
-1.86
Profit Margin (>10% good)
-2.54%
Operating Margin (TTM) (higher better)
-7.04%
ROE (TTM) (>15% strong)
-0.37%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.82
Momentum
Bearish momentum
Value
0.1705
Previous
0.1050
Trend
Rising
Signal Cross
No cross
As of
Sep. 05, 2025